DepoMed Inc. (DEPO) Tops Q1 Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/7/2026
- Wall St futures fall as yields and oil rebound; Fed minutes in focus
- Want to be a stock market bear? BCA says watch potential U.S. tax increases
- SpaceX seeks $40bn in financing for Nvidia chip purchase
- Musk rules out TSMC role in Terafab operations; Intel gains
- U.S. 10-year yield climb revives dotcom-era parallels: UBS weighs in
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Join SI Premium – FREE
After the close, DepoMed Inc. (NASDAQ: DEPO) reported Q1 EPS of $1.77, $0.72 better than the analyst estimate of $1.05. Revenue for the quarter came in at $83.1 million versus the consensus estimate of $81.42 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Beats Q2 EPS by 13c, Revenue Beats, Offers Guidance
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- Neogen Corp. (NEOG) Tops Q1 EPS by 3c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
